Approval · Notice of Compliance 9567 · 2008
ATACAND: Notice of Compliance 9567
Issued May 29, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9567
- Date
- May 29, 2008
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: 32 mg tablet.
- Therapeutic class
- Angiotensin II at1 receptor blocker
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ATACAND | 02311658 | Marketed |
Medicinal ingredients
- CANDESARTAN CILEXETIL 32 MG per TAB